0000899866-19-000052.txt : 20190305 0000899866-19-000052.hdr.sgml : 20190305 20190305202443 ACCESSION NUMBER: 0000899866-19-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190228 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HANTSON LUDWIG CENTRAL INDEX KEY: 0001491435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 19660916 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS, INC STREET 2: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_155183546915912.xml FORM 4 X0306 4 2019-02-28 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001491435 HANTSON LUDWIG C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BLVD BOSTON MA 02210 1 1 0 0 CEO Common Stock, par value $.0001 per share 2019-02-28 4 A 0 37198 0 A 170836 D Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date. /s/ Douglas Barry, Attorney-in-Fact for Ludwig Hantson 2019-03-05